Table 2.
Mortality and Risk, Injury and Failure of Kidney function (RIFLE) criteria
| Total group with AKI |
Total AKI group (RIFLE criteria) n = 172 |
Total group without AKI |
Survivors at 6 months with AKI |
Survivors at 6 months without AKI |
Differences, total group 172/577 |
Differences, survivors 73/325 |
|||
|---|---|---|---|---|---|---|---|---|---|
| Risk | Injury | Failure | |||||||
| Number | 172 | 52 (30.2) | 53 (30.8) | 67 (39.0) | 577 | 73 | 325 | P value | P value |
| Mortality, number (percentage) | 80 (46.5) | 30 (37.5) | 23 (28.8) | 27 (33.8) | 168 (29.1) | - | - | < 0.001 | - |
| RIFLE, number (percentage) Risk | - | 16 (21.9) | - | ||||||
| Injury | 24 (32.9) | ||||||||
| Failure | 33 (45.2) | ||||||||
| CVVH, number (percentage) | 113 (65.7) | 31 (27.4) | 32 (28.3) | 50 (44.2) | 13 (2.3) | 39 (53.4) | 8 (2.5) | < 0.001 | 0.798 |
| CVVH, days | 7 (3-12.5) | 6 (4-11) | 7 (3-11) | 7 (2-15) | 2 (1.5-3.0) | 4 (2-12) | 3 (1.3-4.5) | 0.567 | 0.757 |
| Chronic intermittent hemo-dialysis | 15 | - | - | - | - | - | - | - | - |
| Renal transplant | 2 | - | - | - | - | - | - | - | - |
CVVH, continuous venovenous hemofiltration; RIFLE, Risk, Injury, Failure, Loss, and End-stage kidney disease.